Rhiza Labs FluTracker Forum

The place to discuss the flu
It is currently Thu May 23, 2013 2:09 pm

All times are UTC - 5 hours [ DST ]




Post new topic Reply to topic  [ 5 posts ] 
Author Message
PostPosted: Sun Apr 08, 2012 10:28 am 
Online

Joined: Wed Aug 19, 2009 10:42 am
Posts: 27493
Location: Pittsburgh, PA USA
The CDC has released a series of US 2012 H3N2 sequences with submission dates of 4/6/2012 and 3/30/2012. All of these sequences include antigen characterization data and most are designated as LOW REACTORS. These sequences fall into two major sub-clades. One has A198S and V223I and is related to the new H3N2 vaccine target, A/Victoria/361/2011, while the other has S199A and includes the recent Maryalnd death cluster.

The CDC designations have serious internal inconsistencies, which include identical HA which are classified as Perth/16 LOW in some cases and Perth/16-like in others.

The new batch of LOW REACTORS indicate the virtually all US 2012 H3N2 sequences fall into one of the two LOW REACTOR sub-clades. CDC internally inconsistent designations notwithstanding.

_________________
www.twitter.com/hniman


Top
 Profile  
 
PostPosted: Sun Apr 08, 2012 10:30 am 
Online

Joined: Wed Aug 19, 2009 10:42 am
Posts: 27493
Location: Pittsburgh, PA USA
CDC Identifies 2012 H3N2 Low Reactors In United States
Recombinomics Commentary 12:30
March 20, 2012

A/California/7/2009 (H1N1)pdm09-like virus
A/Victoria/361/2011 (H3N2)-like virus
B/Wisconsin/1/2010-like virus


The above isolates are the vaccine targets for the 2012/2013 season for the northern hemisphere. The H3N2 target was changed from A/Perth/16/2009 which showed a 16 fold reduction (from 2560 to 160) when tested against A/Victoria/361/2011, as demonstrated in table 2 of the February.2012 WHO vaccine update.

This significant drop in titers is linked to the dramatic increase in low reactors reported by the CDC from week 8. At that time the CDC had released 22 H3N2 sequences from 2012, but none were designated as low reactors (only 1/3 had been tested). The antigen characterization data was recently updated, which include the designation of 7 H3N2 isolates from 2012, and 5 of the 7 represented the same sub-clade, which has a number of non-synonymous changes, including A198S and V223I, both of which are also in A/Victoria/361/2011 (collected in late 2011), the new H3 vaccine target.

In addition to the 5 isolates listed as LOW REACTORS, 10 additional isolates mapped as the same sub-clade...........

http://www.recombinomics.com/News/03201 ... 12_LR.html

_________________
www.twitter.com/hniman


Top
 Profile  
 
PostPosted: Sun Apr 08, 2012 2:07 pm 
Online

Joined: Wed Aug 19, 2009 10:42 am
Posts: 27493
Location: Pittsburgh, PA USA
The interal inconsistencies are GLARING. In the latest sets of H3N2 sequences there were 8 sequences that were closely related and on a separate branch. All 8 were from western states (WA, ID, NV, HI). However, only 6 of the 8 were designated as LOW REACTORS. One branch of this branch had 4 sequences from WA. WA/10 and WA/12 were identical and designated as low reactors. ID/04 evolved from these sequuences and was also labeled as a LOW REACTOR. as did WA/11. However, WA/16 was between the other thre WA sequences, yet was designated as Perth/16-like. Similarly, another branch had NV/08 which was a LOW REACTOR. However ID/06 had an IDENTICAL HA sequnece but was listed as Perth/16-like.

Thus, it is clear that the CDC designations are dependent on experimental conditions and fluctuate (probably due to HA concentrations in the isolates).

This internal inconsistency extends well beyond the above examples. The large number of LOW REACTOR sequences in both sub-clades indicates ALL such sequences are LOW REACTORS and cover virtually all 2012 H3N2 sequences in the United States.

_________________
www.twitter.com/hniman


Top
 Profile  
 
PostPosted: Mon Apr 09, 2012 6:18 am 
Online

Joined: Wed Aug 19, 2009 10:42 am
Posts: 27493
Location: Pittsburgh, PA USA
INFLUENZA (25): H3N2 SURVEILLANCE CANADA (BRITISH COLUMBIA), USA
****************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org
[1]Date: Sat 7 Apr 2012
From: Danuta Skowronski


Re: Influenza in previously vaccinated children (USA Pacific Northwest)
-----------------------------------------------------------
In response to Dr. Wilson's ProMED posting of 6 Apr 2012 [Influenza (24): USA (Pacific NW) 20120406.1092588] querying variation in recent influenza A/H3N2 viruses away from the A/Perth/16/2009-like vaccine strain component of the seasonal trivalent influenza vaccine (TIV) since 2010-11 we would like to share findings from the sentinel surveillance system in Canada. Our findings for 2010-11, currently in press with Clinical Infectious Diseases [1], are also relevant to Dr. Wilson's queries for the 2011-12 season.

During the 2010-11 season, H3N2 viruses dominated among influenza detections in Canada and through phylogenetic analysis we identified two variant clades among strains circulating through the sentinel system [1]. Viruses belonging to the A/Hong Kong/2121/2010 clade comprised nearly 90% and those belonging to the A/Victoria/208/2009 clade about 10% of sequenced strains. Based on phylogenetic analysis, few belonged to the A/Perth/16/2009 vaccine clade. Both variant clades showed substantial amino acid substitutions away from the vaccine strain in key antigenic sites, meeting genetic criteria for potential antigenic drift [2]. Consistent with this, we measured suboptimal vaccine effectiveness for the H3N2 component of TIV that season [1].

For the 2011-12 northern and 2012 southern hemisphere influenza seasons, the A/Perth/16/2009 vaccine strain was retained as H3N2 component but has been replaced for the 2012-13 TIV by A/Victoria/361/2009 [3]. The latter belongs to the A/Victoria/208/2009 clade we identified through sentinel surveillance in Canada in 2010-11, but has accumulated further mutations in antigenic sites [1].

In British Columbia, we have identified more significant contribution from the A/Victoria phylogenetic clade this season and given our geographic proximity, the same may also be anticipated in the USA Pacific Northwest. The most recent surveillance bulletin for Washington state reports that 10/22 H3N2 viruses characterized to date for 2011-12 show reduced titres with antiserum produced against the A/Perth/16/2009 vaccine strain [4]. In that regard, suboptimal protection among vaccinated children this season may not be unexpected. It would be informative if the viruses detected by Dr. Wilson and colleagues were also strain characterized and sequenced to better elucidate their identity.

We should point out that influenza B has also been a contributor to influenza activity in British Columbia in recent weeks, with some lineage-level mismatch to the vaccine component noted among characterized strains, a finding also in common with Washington state [4].

References:

1. Skowronski DM, Janjua NZ, De Serres G, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 season. Clinical Infectious Diseases [in press].

2. Bush RM, Bender CA, Subbarao K, Cox NJ, Fitch WM. Predicting the evolution of human influenza A. Science 1999;286:1921-5.

3. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Available at:
http://www.who.int/influenza/vaccines/v ... dation.pdf

4. Washington State Department of Health. Communicable Disease Epidemiology Influenza
Update. 2012 CDC Week 13 (3/25/12 - 3/31/12). Available at:
http://www.doh.wa.gov/EHSPHL/Epidemiolo ... update.pdf

--
Danuta M Skowronski MD, FRCPC
Naveed Z Janjua MBBS, DrPH
Jennifer L Gardy PhD
Communicable Disease Prevention and Control Services

and

Suzana Sabaiduc BSc
Martin Petric PhD, FCCM
BC Public Health Microbiology and Reference Laboratory
BC Centre for Disease Control
Vancouver, British Columbia, Canada

*****
[2]
Date: 7 Apr 2012
From: James M. Wilson V


We have report of another metropolitan hospital in the Pacific NW seeing influenza in previously vaccinated children.

Here in western Colorado, we saw the death of an elderly woman who had a prior medical history of chronic pulmonary disease. Both she and her husband were vaccinated for influenza, but the husband was the first to be infected, then the wife who later succumbed.

--
James M. Wilson V, M.D.
Delta Pediatrics
Delta County Memorial Hospital
-and-
Chief of Station
Ascel Bio Black Canyon Infectious Disease Forecast Station #1

[ProMED thanks Dr. Skowronski and colleagues for their communication supporting antigenic drift of influenza A strains as one of the factors responsible for infection in vaccinated individuals in the adjacent Northwestern USA, such as those noted by Dr. Wilson. - Mod.LM

A HealthMap/ProMED-mail map can be accessed at: http://healthmap.org/r/1*kk.]


See Also

Influenza (24): USA (Pacific NW) 20120406.1092588
Influenza (23): surveillance policy 20120404.1090248
Influenza (22): surveillance policy 20120402.1086648
Influenza (21): update 20120330.1085988
Influenza (20): host susceptibility gene identified 20120328.1083177
Influenza (19): ECDC update 20120323.1078987
Influenza (18): WHO update 20120316.1072674
Influenza (17): WHO Update 20120303.1059811]
.................................................cp/lm

_________________
www.twitter.com/hniman


Top
 Profile  
 
PostPosted: Tue Apr 10, 2012 10:18 am 
Online

Joined: Wed Aug 19, 2009 10:42 am
Posts: 27493
Location: Pittsburgh, PA USA
Published Date: 2012-04-06 17:17:58
Subject: PRO/EDR> Influenza (24): USA (Pacific NW)
Archive Number: 20120406.1092588

INFLUENZA (24): UNITED STATES OF AMERICA (PACIFIC NORTH WEST)
**************************************************************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org
Date: Thu 5 Apr 2012
From: James Wilson [edited]



Influenza in Previously Vaccinated Children (USA Pacific Northwest)
-------------------------------------------------------------------
We have report of a significant bump in influenza-positive pediatric patients presenting to a major metropolitan hospital in the Pacific NW, USA, over the last 2-3 weeks. Of note, many of these patients were previously vaccinated for influenza at the start of the school year (September 2011).

Differential diagnosis (in order of probability):

1. Waning immunity as the predominant type A influenza circulating is H3N2 in the Pacific NW. Waning immunity over the course of a routine influenza season is an expected phenomenon. Our team forecasted a moderate vaccine drift probability for A/H3N2 this season several months ago.

2. Waning immunity as there are still significant levels of circulating A/H1N1 (2009) in the Pacific NW. We believe this is highly unlikely and forecasted very low probabilities of vaccine drift for A/H1N1.

3. Possible emergence of other type A influenza viruses such as A/H3N2-variant. While we believe this is unlikely, we cannot exclude it. One of the key indicators we have been monitoring is the appearance of influenza in patients who were previously vaccinated.

--
James M. Wilson V, M.D.
Department of Pediatrics
Delta County Memorial Hospital
and
Chief of Station
Ascel Bio Black Canyon Infectious Disease Forecast Station

[Perhaps of relevance to the above is the the Eurosurveillance Weekly influenza surveillance overview -- 5 Apr 2012 (http://ecdc.europa.eu/en/publications/P ... R-WISO.pdf) where it was reported that the 2011/12 influenza season started late and has been without any clear geographic progression across Europe. Furthermore, In relation to the situation in the Pacific Northwest described above, it was concluded that there has been a degree of heterogeneity in the antigenicity of the A(H3) viruses this season and an imperfect fit with the A(H3) component in the seasonal vaccine. - Mod.CP

A HealthMap/ProMED-mail map can be accessed at: http://healthmap.org/r/1hiS.]


See Also

Influenza (23): surveillance policy 20120404.1090248
Influenza (22): surveillance policy 20120402.1086648
Influenza (21): update 20120330.1085988
Influenza (20): host susceptibility gene identified 20120328.1083177
Influenza (19): ECDC update 20120323.1078987
Influenza (18): WHO update 20120316.1072674
Influenza (17): WHO Update 20120303.1059811
Influenza (16): (Kazakhstan), bat 20120228.1055577
Influenza (15): (Guatemala) bat, novel A lineage 20120228.1055191
Influenza (14): Europe 20120227.1054422
Influenza (13): 2012-2013 northern hemisphere vaccine 20120223.1050384
Influenza (12): H3N2v pandemic potential 20120222.1049306
Influenza (11): WHO update 20120217.1045169
Influenza (10): New Zealand (AU) airport ex Japan 20120213.1040743
Influenza (09): Viet Nam, new strain?, RFI 20120209.1037688
Influenza (08): WHO Update 20120204.1032238
Influenza (07): Spain (CN) 20120203.1031736
Influenza (06): Mexico 20120130.1026907
Influenza (05): Europe, H3N2 predominant 20120129.1025762
Influenza (04): Japan (SA), nosocomial 20120127.1024071
Influenza (03): WHO update 20120120.1016834
Influenza (02): WHO update 20120106.1001987
Influenza: USA (OH) institutional children with neuro conditions 20120105.1001023]
.................................................cp/ejp/lm

_________________
www.twitter.com/hniman


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 5 posts ] 

All times are UTC - 5 hours [ DST ]


Who is online

Users browsing this forum: gsgs, littlebird, meteorjosh, niman and 76 guests


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:
Jump to:  
Powered by phpBB® Forum Software © phpBB Group